leqembi eisai news - Search News

Alzheimer's, Biogen and Leqembi

FiercePharma · 1d

EMA changes tune, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | Upon reexamination, the EMA has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi.

Reuters on MSN · 22h

EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with early Alzheimer's disease, reversing its initial decision from four months ago.

Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved.

Zacks.com on MSN1h

Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe

The CHMP renders a positive opinion recommending approval for BIIB and Eisai's Leqembi for treating early Alzheimer's disease ...

EU regulators endorse meds from BMS, J&J, Eisai and more—plus a clutch of biosims

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

4d

Eisai: Still Relatively Modest Market-Implied Expectations For Leqembi

Analysis of Leqembi's commercial potential and market outlook, with a focus on growth projections and investment ...

EU Backs Leqembi: A Breakthrough in Alzheimer's Treatment

The European Union's drugs regulator has recommended approval for Eisai and Biogen's Alzheimer's drug Leqembi. This marks a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results